Drug-Induced Hearing Loss

  • Leonard P. Rybak
  • Andra E. Talaska
  • Jochen Schacht
Part of the Springer Handbook of Auditory Research book series (SHAR, volume 31)


Hearing Loss Hair Cell Aminoglycoside Antibiotic Stria Vascularis Hair Cell Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alam SA, Ikeda K, Oshima T, Suzuki M, Kawase T, Kikuchi T, Takasaka T (2000) Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res 141:28–38.PubMedGoogle Scholar
  2. Albinger-Hegyi A, Hegyi I, Nagy I, Bodmer M, Schmid S, Bodmer D (2006) Alteration of activator protein 1 DNA binding activity in gentamicin-induced hair cell degeneration. Neuroscience137:971–980.PubMedGoogle Scholar
  3. Aran JM, Darrouzet J (1975) Observation of click-evoked compound VIII nerve responses before, during and over seven months after kanamycin treatment in the guinea pig. Acta Otolaryngol 79:24–32.PubMedGoogle Scholar
  4. Arbuzova A, Martushova K, Hangyas-Mihalyne G, Morris AJ, Ozaki S, Prestwich GD, McLaughlin S (2000) Fluorescently labeled neomycin as a probe of phosphatidylinositol-4,5-bisphosphate in membranes. Biochimica Biophys Acta 1464:35–48.Google Scholar
  5. Barron SE, Daigneault EA (1987) Effect of cisplatin on hair cell morphology and lateral wall Na, K-ATPase activity. Hear Res 26:131–137.PubMedGoogle Scholar
  6. Battaglia A, Pak K, Brors D, Bodmer D, Frangos JA, Ryan AF (2003) Involvement of ras activation in toxic hair cell damage of the mammalian cochlea. Neuroscience 122:1025–1035.PubMedGoogle Scholar
  7. Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O (2004) Platinum compound-related ototoxicity in children. Long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol 26:649–655.PubMedGoogle Scholar
  8. Black FO, Pesznecker S, Stallings V (2004) Permanent gentamicin vestibulotoxicity. Otol Neurotol 25:559–596.PubMedGoogle Scholar
  9. Blakley BW (1997) Clinical forum: a review of intratympanic therapy. Am J Otol 18:520–526.PubMedGoogle Scholar
  10. Blakley BW, Gupta AK, Myers SF, Schwan S (1994) Risk factors for ototoxicity due to cisplatin. Arch Otolaryngol Head Neck Surg 120:541–546.PubMedGoogle Scholar
  11. Benedetti Panici P, Greggi S, Scambia G, Baiocchi G, Lomonaco M, Conti G, Mancuso S (1993) Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up. Int J Gynecol Cancer 3:44–53.PubMedGoogle Scholar
  12. Bock GR, Yates GK, Miller JJ, Moorjani P (1983) Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig. Hear Res 9:255–262.PubMedGoogle Scholar
  13. Bodmer D, Brors D, Bodmer M, Ryan AF (2002a) Rescue of auditory hair cells from ototoxicity by CEP-11 004, an inhibitor of the JNK signaling pathway. Laryngorhinootologie 81:853–856.Google Scholar
  14. Bodmer D, Brors D, Pak K, Gloddek B, Ryan A (2002b) Rescue of auditory hair cells from aminoglycoside toxicity by Clostridium difficile toxin B, an inhibitor of the small GTPases Rho/Rac/Cdc42. Hear Res 172:81–86.Google Scholar
  15. Boheim K, Bichler E (1985) Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology. Arch Otorhinolaryngol 242:1–6.PubMedGoogle Scholar
  16. Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz L (1998) Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 77:1355–1362.PubMedGoogle Scholar
  17. Bose RN (2002) Biomolecular targets for platinum antitumor drugs. Mini Rev Med Chem 2:103–111.PubMedGoogle Scholar
  18. Boulikas T, Vougiouka M (2004) Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncol Rep 11:559–565.PubMedGoogle Scholar
  19. Brouet G, Marche J, Chevallier J, Liot F, LE Meur G, Bergogne (1959) Étude expérimentale et clinique de la kanmycine dans l’infection tuberculeuse. Re Tub Pneum 23:949–988.Google Scholar
  20. Campbell KCM, Rybak LP, Meech RP, Hughes L (1996) D-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 102:90–98.PubMedGoogle Scholar
  21. Campbell KC, Meech RP, Rybak LP (1999) D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 138:13–28.PubMedGoogle Scholar
  22. Caussé R, Gondet I, Vallancien B (1949) Action de la streptomycine sur les cellules ciliées des organes vestibulaires de la souris. Compt Rend Soc Biol 143:619–620.Google Scholar
  23. Cheng AG, Cunningham LL, Rubel EW (2003) Hair cell death in the avian basilar papilla: characterization of the in vitro model and caspase activation. J Assoc Res Otolaryngol 4:91–105.PubMedGoogle Scholar
  24. Cheng AG, Cunningham LL, Rubel EW (2005) Mechanisms of hair cell death and protection. Curr Opin Otolaryngol Head Neck Surg 13:343–348.PubMedGoogle Scholar
  25. Choe WT, Chinosornvatana N, Chang KW (2004) Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol 25:910–915.PubMedGoogle Scholar
  26. Church MW, Blakley BW, Burgio DL, Gupta AK (2004) WR-2721 (amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters. J Assoc Res Otolaryngol 5:227–237.PubMedGoogle Scholar
  27. Clerici WJ, Hensley K, DiMartino DL, Butterfield DA (1996) Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 98:116–124.PubMedGoogle Scholar
  28. Corrado AP, de Morais IP, Prado WA (1989) Aminoglycoside antibiotics as a tool for the study of the biological role of calcium ions. Historical overview. Acta Physiol Pharmacol Latinoamer 39:419–430.Google Scholar
  29. Cunningham LL, Matsui JI, Warchol ME, Rubel EW (2004) Overexpression of Bcl-2 prevents neomycin-induced hair cell death and caspase-9 activation in the adult mouse utricle in vitro. J Neurobiol 60:89–100.PubMedGoogle Scholar
  30. Dai CF, Mangiardi D, Cotanche DA, Steyger PS (2006) Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo. Hear Res 213:64–78.PubMedGoogle Scholar
  31. Darrouzet J, Guilhaume A (1974) Ototoxicité de la kanamycine au jour le jour. Étude expérimentale en microscopie électronique. Rev Laryng (Bordeaux) 95:601–621.Google Scholar
  32. Davis H, Deatherage BH, Rosenblut B, Fernandez C, Kimura R, Smith CA (1958) Modification of cochlear potentials produced by streptomycin poisoning and by extensive venous obstruction. Laryngoscope 68:596–627.PubMedGoogle Scholar
  33. de Jager P, van Altena R (2002) Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. Int J Tuberc Lung Dis 6:622–627.PubMedGoogle Scholar
  34. DeConti RC, Toftness BR, Lange RC, Creasey A (1973) Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Res 33:1310–1315.PubMedGoogle Scholar
  35. DeGroot JC, Hamers FP, Gispen WH, Smoorenberg GF (1997) Co-administration of the neurotropic ACTH (4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin. Hear Res 106:9–19.Google Scholar
  36. Dehne N, Lautermann J, Petrat F, Rauen U, de Groot H (2001) Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 174:27–34.PubMedGoogle Scholar
  37. Dehne N, Rauen U, de Groot H, Lautermann J (2002). Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear Res 169:47–55.PubMedGoogle Scholar
  38. Devarajan P, Savoca M, Castaneda MP, Park MS, Esteban-Cruciani N, Kalinec G, Kalinec F (2002) Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways. Hear Res 174:45–54.PubMedGoogle Scholar
  39. Ding D, Stracher A, Salvi RJ (2002) Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res. 2002 164:115–26. Erratum in: Hear Res. 2003 180:129.Google Scholar
  40. Dulon D, Aran JM, Zajic G, Schacht J (1986) Comparative pharmacokinetics of gentamicin, netilmicin and amikacin in the cochlea and the vestibule of the guinea pig. Antimicrob Agents Chemother 30:96–100.PubMedGoogle Scholar
  41. Dulon D, Zajic G, Aran JM, Schacht J (1989) Aminoglycoside antibiotics impair calcium-entry but not viability and motility of cochlear outer hair cells. J Neurosci Res 24:338–346.PubMedGoogle Scholar
  42. Dulon D, Hiel H, Aurousseau C, Erre JP, Aran JM (1993) Pharmacokinetics of gentamicin in the sensory hair cells of the organ of Corti: rapid uptake and long term persistence. C.R. Acad Sci III 316:682–687.Google Scholar
  43. Ekborn A, Hansson J, Ehrsson H, Eksborg S, Wallin I, Wagenius G, Laurell G. (2004) High dose cisplatin with amifostine: ototoxicity and pharmacokinetics. Laryngoscope 114:1660–1667.PubMedGoogle Scholar
  44. Estrem SA, Babin RW, Ryu JH, Moore KC (1981) Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig. Otolaryngol Head Neck Surg 89:638–645.PubMedGoogle Scholar
  45. Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, McDonald WJ (1992) High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis165:1026–1032.PubMedGoogle Scholar
  46. Fausti SA, Frey RH, Henry JA, Olson DJ, Schaffer HI (1993) High-frequency monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg 119:661–666.PubMedGoogle Scholar
  47. Federspil P (1979) Antibiotikaschöden des Ohres. Barth: Leipzig.Google Scholar
  48. Fee WE (1980) Aminoglycoside ototoxicity in the human. Laryngoscope 40:1–19.Google Scholar
  49. Feun LG, Wallace S, Stewart DJ, Chuang VP, Yung WK, Leavens ME, Burgess MA, Savaraj N, et al. (1984) Intracarotid infusion of cis-dichlorodiammineplatinum (II) in the treatment of recurrent malignant brain tumors. Cancer 54:794–799.PubMedGoogle Scholar
  50. Fischel-Ghodsian N (2005) Genetic factors in aminoglycoside toxicity. Pharmacogenomics 6:27–36.PubMedGoogle Scholar
  51. Fleischman RW, Stadnicki SW, Ethier MF, Schaeppi U (1975) Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig. Toxicol Appl Pharmacol 33:320–332.PubMedGoogle Scholar
  52. Forge A, Li L (2000) Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res 139:97–115.PubMedGoogle Scholar
  53. Forge A, Schacht J (2000) Aminoglycoside Antibiotics. Audiol Neurootol 5:3–22.PubMedGoogle Scholar
  54. Forge A, Fradis M (1985) Structural abnormalities in the stria vascularis following chronic gentamicin treatment. Hear Res 20:233–244.PubMedGoogle Scholar
  55. Forge A, Wright A, Davies SJ (1987) Analysis of structural changes in the stria vascularis following chronic gentamicin treatment. Hear Res 31:253–266.PubMedGoogle Scholar
  56. Forge A, Li L, Corwin JT, Nevill G (1993) Ultrastructural evidence for hair cell regeneration in the mammalian inner ear. Science 259:1616–1619.PubMedGoogle Scholar
  57. Forge A, Li L, Nevill G (1998) Hair cell recovery in the vestibular sensory epithelia of mature guinea pigs. J Comp Neurol 397:69–88.PubMedGoogle Scholar
  58. Fuertes MA, Castilla J, Alonso C, Perez JM (2003) Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10:257–266.Google Scholar
  59. Garetz SL, Altschuler RA, Schacht J (1994a) Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hear Res 77:81–87.Google Scholar
  60. Gonzalez VM, Fuertes MA, Alonso C, Perez JM (2001) Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 59:657–663.PubMedGoogle Scholar
  61. Gormley PE, Bull JM, LeRoy AF, Cysyk R (1979) Kinetics of cis-dichlorodiammine-platinum. Clin Pharmacol Ther 25:351–357.PubMedGoogle Scholar
  62. Grunberg SM, Sonka S, Stevenson LL, Muggia FM (1989) Progressive paresthesias after cessation of therapy with very high-dose cisplatin. Cancer Chemother Pharmacol 2:62–64.Google Scholar
  63. Halmagyi GM, Fattore CM, Curthoys IS, Wade S (1994) Gentamicin vestibulotoxicity. Otolaryngol Head Neck Surg 111:571–574.PubMedGoogle Scholar
  64. Hamasaki K, Rando RR (1997) Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness. Biochem 36:12323–12328.Google Scholar
  65. Hawkins JE (1973) Ototoxic mechanisms: a working hypothesis. Audiology 12:383–393.PubMedGoogle Scholar
  66. Hawkins JE (1976) Drug ototoxicity. In: Keidel WD, Neff WD (eds) Handbook of Sensory Physiology. Berlin: Springer Verlag, 5(3) pp. 707–748.Google Scholar
  67. Hawkins JE, Beger V, Aran JM (1967) Antibiotic insults to Corti’s organ. In: Graham AB (ed) Sensorineural Hearing Processes and Disorders. Boston: Little Brown Co, pp. 411–425.Google Scholar
  68. Henley CM, Schacht J (1988) Pharmacokinetics of aminoglycoside antibiotics in blood, inner ear fluids and tissues and their relationship to ototoxicity. Audiology 27:137–146.PubMedGoogle Scholar
  69. Henry KR, Chole RA, McGinn MD, Frush DP (1981) Increased ototoxicity in both young and old mice. Arch Otolaryngol 107:92–95.PubMedGoogle Scholar
  70. Hershko, C (1992) Iron chelators in medicine. Molec Asp Med 13:113–165.Google Scholar
  71. Himmelstein KJ, Patton TF, Belt RJ, Taylor S, Repta AJ, Sternson LA (1981) Clinical kinetics on intact cisplatin and some related species. Clin Pharmacol Ther 29:658–664.PubMedGoogle Scholar
  72. Hinojosa R, Lerner SA (1987) Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity. J Infect Dis 156:449–555.PubMedGoogle Scholar
  73. Hinojosa R, Riggs LC, Strauss M, Matz GJ (1995) Temporal bone histopathology of cisplatin ototoxicity. Am J Otol 16:731–740.PubMedGoogle Scholar
  74. Hinshaw HC, Feldman WH (1945) Streptomycin in treatment of clinical tuberculosis: a preliminary report. Proc Mayo Clinic 20:313–318.Google Scholar
  75. Hirose K, Hockenberry DN, Rubel EW (1997) Reactive oxygen species in chick hair cells after gentamicin exposure in vitro. Hear Res 104:1–14.PubMedGoogle Scholar
  76. Hirose K, Westrum LE, Stone JS, Zirpel L, Rubel EW (1999) Dynamic studies of ototoxicity in mature avian auditory epithelium. Ann NY Acad Sci 884:389–409.PubMedGoogle Scholar
  77. Hoistad DL, Ondrey FG, Mutlu C, Schachern PA, Paparella MM, Adams GL (1998) Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg 118:825–832.PubMedGoogle Scholar
  78. Hu DN, Qui WQ, Wu BT, Fang LZ, Zhou F, Gu YP, Zhang QH, Yan JH, et al. (1991) Genetic aspects of antibiotic induced deafness: mitochondrial inheritance. J Med Genet 28:79–83.PubMedGoogle Scholar
  79. Huang DC, Strasser A (2000) BH-3-Only proteins—essential initiators of apoptotic cell death. Cell 103:839–842.PubMedGoogle Scholar
  80. Imamura S, Adams JC (2003) Distribution of gentamicin in the guinea pig inner ear after local or systemic application. JARO 4:176–195.PubMedGoogle Scholar
  81. Iraz M, Kalcioglu MT, Kizilay A, Karatas E (2005) Aminoguanidine prevents ototoxicity induced by cisplatin in rats. Ann Lab Clin Sci 35:329–335.Google Scholar
  82. Ishida S, Lee J, Thiele DJ, Herskowita I (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99:14298–14302.PubMedGoogle Scholar
  83. Jiang H, Sha SH, Schacht J (2005) The NF-UP kappa B pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J Neurosci Res 79:644–651.PubMedGoogle Scholar
  84. Jiang H, Sha SH, Forge A, Schacht J (2006a) Caspase-independent pathways of hair cell death induced by kanamycin in vivo. Cell Death Diff 13:20–30.Google Scholar
  85. Jiang H, Sha SH, Schacht J (2006b) Rac/Rho pathway regulates actin depolymerization induced by aminoglycoside antibiotics. J Neurosci Res 83:1544–1551.Google Scholar
  86. Johnsson LG, Hawkins JE Jr, Kingsley TC, Black FO, Matz GJ (1981) Aminoglycoside-induced cochlear pathology in man. Acta Otolaryngol S383:1–19.Google Scholar
  87. Kalinec GM, Webster P, Lim DJ, Kalinec F (2003) A cochlear cell line as an in vitro system for drug ototoxicity screening. Audiol Neurootol 8:177–189.PubMedGoogle Scholar
  88. Kalinec GM, Fernandez-Zapico ME, Urrutia R, Esteban-Cruciani N, Chen S, Kalinec F (2005) Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss. Proc Natl Acad Sci USA 102:16019–16024.PubMedGoogle Scholar
  89. Kawai Y, Kohda Y, Kodawara T, Gemba M (2005) Protective effect of a protein kinase inhibitor on cellular injury induced by cephaloridine in the porcine kidney cell line LLC-PK(1). J Toxicol Sci 30:157–122.PubMedGoogle Scholar
  90. Kawamoto K, Sha SH, Minoda R, Izumikawa M, Kuriyama H, Schacht J, Raphael Y (2004) Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 9:173–181.PubMedGoogle Scholar
  91. Kelly TC, Whitworth CA, Husain K, Rybak LP (2003) Aminoguanidine reduces cisplatin ototoxicity. Hear Res 186:10–16PubMedGoogle Scholar
  92. Klis SF, O’Leary SJ, Hamers FP, De Groot JC, Smoorenburg GF (2000) Reversible cisplatin ototoxicity in the albino guinea pig. Neuro Report 11:623–626.Google Scholar
  93. Knoll C, Smith RJH, Shores C, Blatt J (2006) Hearing genes and cisplatin deafness: a pilot study. Laryngoscope 116:72–74.PubMedGoogle Scholar
  94. Komune S, Ide M, Nakano T, Morimitsu T (1987) Effects of kanamycin sulfate on cochlear potentials and potassium ion permeability through the cochlear partitions. ORL 49:9–16.PubMedCrossRefGoogle Scholar
  95. Kopke RD, Liu W, Gabaizadeh R, Jacono A, Feghali J, Spray D, Garcia P, Steinman H, et al. (1997) The use of organotypic cultures of Corti’s organ to study the protective effects of antioxidant molecules on cisplatin induced damage of auditory hair cells. Am J Otol 18:559–571.PubMedGoogle Scholar
  96. Kossl M, Richardson GP, Russell IJ (1990) Stereocilia bundle stiffness: effects of neomycin, A23187 and concanavalin A. Hear Res 44:217–230.PubMedGoogle Scholar
  97. Kovach JS, Moertel CG, Schutt AJ, Reitemeier RG, Hahn RG (1973) Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Cancer Chemother Rep 57:357–359.PubMedGoogle Scholar
  98. Kroese ABA, van den Bercken J (1982) Effects of ototoxic antibiotices on sensory hair cell functioning. Hear Res 6:183–197.Google Scholar
  99. Kroese ABA, Das A, Hudspeth AJ (1989) Blockage of the transduction channels of hair cells in the bull frog’ sacculus by aminoglycoside antibiotics. Hear Res 37:203–218.PubMedGoogle Scholar
  100. Ladrech S, Guitton M, Saido T, Lenoir M (2004) Calpain activity in the amikacin-damaged rat cochlea. J Comp Neurol 477:149–60.PubMedGoogle Scholar
  101. Laurell G, Bagger-Sjoback D (1991) Dose-dependent inner ear changes after IV administration of cisplatin. J Otolaryngol 20:158–167.PubMedGoogle Scholar
  102. Laurell G, Jungnelius U (1990) High-dose cisplatin treatment: hearing loss and plasma concentrations. Laryngoscope 100:724–734.PubMedGoogle Scholar
  103. Lautermann J, McLaren J, Schacht J (1995) Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear Res 86:15–24.PubMedGoogle Scholar
  104. Leake PA, Hradek GT (1988) Cochlear pathology of long term neomycin induced deafness in cats. Hear Res 33:11–33.PubMedGoogle Scholar
  105. Lee JE, Nakagawa T, Kim TS, Endo T, Shiga A, Iguchi F, Lee SH, Ito J (2004a) Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment. Acta Otolaryngol 124:1131–1135.Google Scholar
  106. Lee JE, Nakagawa T, Kim TS, Endo T, Shiga A, Iguchi F, Lee SH, Ito J (2004b) Mechanisms of apoptosis induced by cisplatin in marginal cells in mouse stria vascularis. ORL 66, 111–118.Google Scholar
  107. Leist M, Jööttelö M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Revs 2:1–10.Google Scholar
  108. Lerner SA, Schmitt BA, Seligsoh, Matz R (1986) Comparative-study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med 80:98–104.Google Scholar
  109. Lesniak W, Pecoraro VL , Schacht J (2005)Ternary complexes of gentamicin with iron and lipid catalyze formation of reactive oxygen species. Chem Res Toxicol 18:357–364.PubMedGoogle Scholar
  110. Li G, Sha SH, Zotova E, Arezzo J, Van de Water T, Schacht J (2002) Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 82:585–596.PubMedGoogle Scholar
  111. Li L, Nevill G, Forge A (1995) Two modes of hair cell loss from the vestibular sensory epithelia of the guinea pig. J Comp Neurol 355:405–417.PubMedGoogle Scholar
  112. Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: the influence of age and cumulative dose. Eur J Cancer 40:2445–2451.PubMedGoogle Scholar
  113. Liang F, Schulte BA, Qu C, Hu W. (2005) Inhibition of the calcium- and voltage-dependent big conductance potassium channel ameliorates cisplatin-induced apoptosis in spiral ligament fibrocytes of the cochlea. Neuroscience 135:263–271.PubMedGoogle Scholar
  114. Liedert B, Pluim D, Schellens J, Thomale J (2006) Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei. Nucleic Acids Res 34:[epub March 29, 2006].Google Scholar
  115. Lim D (1986) Effects of noise and ototoxic drugs at the cellular level in the cochlea: a review. Am J Otolaryngol 7:73–99.PubMedGoogle Scholar
  116. Lindemann HH (1969) Regional differences in sensitivity of the vestibular sensory epithelia to ototoxic antibiotics. Acat Otolaryngol 67:177–189.Google Scholar
  117. Lippman AJ, Helson C, Helson L, Krakoff IH (1973) Clinical trials of cis-diammine- dichloroplatinum (NSC-119875). Cancer Chemother Rep 57:191–200.PubMedGoogle Scholar
  118. Liu W, Staecker H, Stupak H, Malgrange B, Lefebvre P, Van De Water TR. (1998) Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuro Report 9:2609–2614.Google Scholar
  119. Lu YF (1987) Cause of 611 deaf mutes in schools for deaf children in Shanghai. Shanghai Med J 10:159.Google Scholar
  120. Lynch ED, Gu R, Pierce C, Kil J (2005a) Reduction of acute cisplatin ototoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201: 81–89.Google Scholar
  121. Lynch ED, Gu R, Pierce C, Kil J (2005b) Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity. Anticancer Drugs 16: 569–579.Google Scholar
  122. Magnet S, Blanchard JS (2005) Molecular insights into aminoglycoside action and resistance. Chem Rev 105:477–497.PubMedGoogle Scholar
  123. Mangiardi DA, McLaughlin-Williamson K, May KE, Messana EP, Mountain DC, Cotanche DA (2004) Progression of hair cell ejection and molecular markers of apoptosis in the avian cochlea following gentamicin treatment. J Comp Neurol 475:1–18.PubMedGoogle Scholar
  124. Marco-Algarra J, Basterra J, Marco J (1985) Cis-diaminedichloroplatinum ototoxicity. An experimental study. Acta Otolaryngol 99:343–347.PubMedGoogle Scholar
  125. Marcotti W, van Netten S, Kros CJ (2005) The aminoglycoside antibiotic dihydrostreptomycin rapidly enters hairs through the mechano-electrical transducer channels. J Physiol 576:505–521.Google Scholar
  126. Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, et al. (2005) Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children’s Oncology Group study. Cancer 104:841–847.PubMedGoogle Scholar
  127. Maroney AC, Glicksman MA, Basma AN, Walton KM, Knight E Jr, Murphy CA, Bartlett BA, Finn JP, et al. (1998) Motoneuron apoptosis is blocked by CEP-1347 (KT 7515): a novel inhibitor of the JNK signaling pathway. J Neurosci 18:104–111.PubMedGoogle Scholar
  128. Marot M, Uziel A, Romand R (1980) Ototoxicity of kanamycin in developing rats: relationship with the onset of the auditory function. Hear Res 2:111–113.PubMedGoogle Scholar
  129. Mathog RH, Klein Jr WJ (1969) Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uremia. N Engl J Med 280:1223–1224.PubMedGoogle Scholar
  130. Matsui JI, Gale JE, Warhol ME (2004) Critical signaling events during the aminoglycoside-induced death of sensory hair cells in vitro. J Neurobiol 61:250–266.PubMedGoogle Scholar
  131. McDonald LJ, Mamrack MD (1995) Phosphoinositide hydrolysis by phospholipase C modulated by multivalent cations La(3+), Al(3+), neomycin, polyamines, and melttin. J Lipid Mediat Cell Signal 11:81–91.PubMedGoogle Scholar
  132. McHugh PJ, Spanswick VJ, Hartley JA (2001) Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol 2:483–490.PubMedGoogle Scholar
  133. Meech RP, Campbell KC, Hughes LF, Rybak LP (1998) A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear Res 124:44–59.PubMedGoogle Scholar
  134. Minami SB, Sha SH, Schacht J (2004) Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hear Res 198:137–143.PubMedGoogle Scholar
  135. Mizuta K, Saito A, Watanabe T, Nagura M, Arakawa M, Shimizu F, Hoshino T (1999) Ultrastructural localization of megalin in the cochlear duct. Hear Res 129:83–91.PubMedGoogle Scholar
  136. Moestrup SK, Cui S, Vorum H, Bregenga°rd C, Bjrn SE, Norris K, Gliemann J, Christensen EI (1995) Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 96:1404–1413.PubMedGoogle Scholar
  137. Moore RD, Smith CR, Lietman PS (1984) Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis 149:23–30.PubMedGoogle Scholar
  138. Mukherjea D, Whitworth CA, Nandish S, Dunaway GA, Rybak LP, Ramkumar V (2006) Expression of the kidney injury molecule (KIM) 1 in the rat cochlea and induction by cisplatin. Neuroscience 139:733–740.PubMedGoogle Scholar
  139. Mulheran M, Degg C, Burr S, Morgan DW, Stableforth DE (2001) Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy. Antimicrob Agents Chemother 45:2502–2509.PubMedGoogle Scholar
  140. Myers SF, Blakley BW, Schwan S (1993) Is cis-platinum vestibulotoxic? Otolaryngol Head Neck Surg 108:322–328.PubMedGoogle Scholar
  141. Nadol JB Jr (1997) Patterns of neural degeneration in the human cochlea and auditory nerve: implications for cochlear implantation. Otolaryngol Head Neck Surg 117:220–228.PubMedGoogle Scholar
  142. Nakagawa T, Yamane H, Takayama M, Sunami K, Nakai Y (1998) Apoptosis of guinea pig cochlear hair cells following aminoglycoside treatment. Eur Arch Otorhinolaryngol 255:127–131.PubMedGoogle Scholar
  143. Ohtsuki K, Ohtani I, Aikawa T, Sato Y (1982) The ototoxicity and the accumulation in the inner ear fluids of the various aminoglycoside antibiotics. Ear Res Jap 13:85–87.Google Scholar
  144. Okuda T, Sugahara K, Takemoto T, Shimogori H, Yamashita H. (2005) Inhibition of caspases alleviates gentamicin-induced cochlear damage in guinea pigs. Auris Nasus Larynx 32:33–37.PubMedGoogle Scholar
  145. Oren M (1999) Regulation of the p53 tumor suppressor protein. J Biol Chem 274: 36031–36034.PubMedGoogle Scholar
  146. Osborn MT, Chambers TC (1996) Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J Biol Chem 271:30950–30955.PubMedGoogle Scholar
  147. Peters U, Preisler-Adams S, Lanvers-Kaminsky C, Jürgens H, Lamprecht-Dinnesen A (2003) Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Res 23:1249–1255.PubMedGoogle Scholar
  148. Pichler M, Wang Z, Grabner-Weiss C, Reimer D, Hering S, Grabner M, Glossmann H, Striessnig J (1996) Plock of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry 35:14659–14664.PubMedGoogle Scholar
  149. Pierson MG, Moller AR (1981) Prophylaxis of kanamycin-induced ototoxicity by a radioprotectant. Hear Res 4:79–87.PubMedGoogle Scholar
  150. Pirvola U, Xing-Qun L, Virkkala J, Saarma M, Murakata C, Camoratto AM, Walton KM, Ylikoski J (2000) Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT-7515, an inhibitor of c-Jun N-terminal kinase activation. J Neurosci 20:43–50.PubMedGoogle Scholar
  151. Pong AL, Bradley JS (2005) Guidelines for the selection of antibacterial therapy in children. Pediatr Clin North Am 52:869–894.PubMedGoogle Scholar
  152. Prezant TR, Agapian JV, Bohlman MC, Bu X Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, et al. (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Gen 4:289–294.Google Scholar
  153. Prim MP, de Diego JI, de Sarria MJ, Gavilan J (2001) Vestibular and oculomotor changes in subjects treated with cisplatin. Acta Otorrinolaringol Esp 52:367–370.PubMedGoogle Scholar
  154. Priuska EM, Schacht J (1995) Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol 50:1749–1752.PubMedGoogle Scholar
  155. Raphael Y, Fein A, Nebel L (1983) Transplacental kanamycin ototoxicity in the guinea pig. Arch Oto-Rhino-Laryngol 238:45–51.Google Scholar
  156. Ravi R, Somani SM, Rybak LP (1995) Mechanism of cisplatin ototoxicity: antioxidant defense system. Pharmacol Toxicol 76:386–394.PubMedCrossRefGoogle Scholar
  157. Reser D, Rho M, Dewan D, Herbst L Li G, Stupak H, Zur K, Romaine J, et al. (1999) l- and d-methioniine provide long-term protection against CDDP-induced ototoxicity in vivo, with partial in vivo and in vitro retention of antineoplastic activity. Neurotoxicology 20:731–748.PubMedGoogle Scholar
  158. Richardson GP, Forge A, Kros CJ, Fleming J, Brown SD, Steel KP (1997) Myosin VIIA is required for aminoglycoside accumulation in cochlear hair cells. J Neurosci 17:9506–9519.PubMedGoogle Scholar
  159. Rosenberg B (1973) Platinum coordination complexes in cancer chemotherapy. Naturwissenschaften 60:399–406.PubMedGoogle Scholar
  160. Rosenberg B (1980) Cisplatin: its history and possible mechanisms of action. In: Prestayko, AW, Crooke ST, Carter SK (eds) Cisplatin: Current Status and New Developments. New York: Academic Press, pp. 9–20.Google Scholar
  161. Rosenberg B, Van Camp L, Krigas T (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205:698–699.PubMedGoogle Scholar
  162. Rosenberg B, Van Camp L, Trosko JE, Mansour VH (1969) Platinum compounds: a new class of potent antitumor agents. Nature 222:385–386.PubMedGoogle Scholar
  163. Rozencweig M, Von Hoff DD, Slavik M, Muggia FM (1977) Cis-ciamminechloro-platinum (II): a new anticancer drug. Ann Intern Med 86:803–812.PubMedGoogle Scholar
  164. Ruedi L, Furrer W, Graf K, Luthy F, Nager G, Tschirren B (1951) Nouvelles constatations sur la toxicité de la streptomycine et de la quinine à l‘égard de l’oreille du cobaye. Rev Laryngol (Bordeaux) 72:238–264.Google Scholar
  165. Ruedi L, Furrer W, Graf K, Nager G, Tschirren B, Luthy F (1952) Further observations concerning the toxic effects of streptomycin and quinine on the auditory organ of guinea pigs. Laryngoscope 62:333–357.PubMedGoogle Scholar
  166. Rybak LP, Whitworth CA (2005) Ototoxicity: therapeutic opportunities. Drug Discovery Today, 10:1313–1321.PubMedGoogle Scholar
  167. Rybak LP, Husain K, Morris C, Whitworth C, Somani S (2000) Effect of protective agents against cisplatin ototoxicity. Am J Otol 21:513–520.PubMedGoogle Scholar
  168. Santoso JT, Lucci JA 3rd, Coleman RL, Schafer I, Hannigan EV (2003) Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial. Cancer Chemother Pharmacol 52:13–18.PubMedGoogle Scholar
  169. Sastry J, Kellie SJ (2005) Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 22:441–445.PubMedGoogle Scholar
  170. Schacht J (1979) Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney. Arch Otorhinolaryngol 224:129–134PubMedGoogle Scholar
  171. Schacht J, Hawkins JE (2006) Sketches of Otohistory. Part 11: Ototoxicity: Drug-induced hearing loss. Audiol Neurotol 11:1–6.Google Scholar
  172. Schatz A, Bugie E, Waksman SA (1944) Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc Soc Exp Biol Med 55:66–69.Google Scholar
  173. Schuknecht HF (1993) Pathology of the Ear. Philadelphia: Lea & Febiger, pp. 273–274.Google Scholar
  174. Schweitzer VG (1993) Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 26: 759–785.PubMedGoogle Scholar
  175. Sergi B, Ferraresi A, Troiani D, Paludetti G, Fetoni AR (2003) Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hear Res 182:56–64.PubMedGoogle Scholar
  176. Sha SH, Schacht J (1999a) Formation of reactive oxygen species following bioactivation of gentamicin. Free Radic Biol Med 26:341–347.Google Scholar
  177. Sha SH, Schacht J (1999b) Salicylate attenuates gentamicin-induced ototoxicity. Lab Invest 79:807–813.Google Scholar
  178. Sha SH, Qiu JH, Schacht J (2006) Aspirin attenuates gentamicin-induced hearing loss. New Engl J Med 354:1856–1857.PubMedGoogle Scholar
  179. Sha SH, Zajic G, Epstein CJ, Schacht J (2001) Overexpression of SOD protects from kanamycin-induced hearing loss. Audiol Neuro-Otol 6:117–123.Google Scholar
  180. Shani J, Bertram J, Russell C, Dahalan R, Chen DC, Parti R, Ahmadi J, Kempf RA, et al. (1989) Noninvasive monitoring of drug distribution and metabolism: studies with intraarterial Pt-195m-cisplatin in humans. Cancer Res 49:1877–1881.PubMedGoogle Scholar
  181. Shimizu A, Takumida M, Anniko M, Suzuki M (2003) Calpain and caspase inhibitors protect vestibular sensory cells from gentamicin ototoxicity. Acta Otolaryngol 123:459–465.PubMedGoogle Scholar
  182. Sone M, Schachern PA, Paparella MM (1998) Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity. Hear Res 115:217–223.PubMedGoogle Scholar
  183. Song BB, Schacht J (1996) Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear Res 94:87–93.PubMedGoogle Scholar
  184. Song BB, Sha SH, Schacht J (1998) Iron chelators protect from aminoglycoside-induced cochleo- and vestibulotoxicity in guinea pig. Free Radical Biol Med 25:189–195.Google Scholar
  185. Steyger PS (2005) Cellular uptake of aminoglycosides. Volta Rev 105:299–324.Google Scholar
  186. Strauss M, Towfighi J, Lord S, Lipton A, Harvey HA, Brown B (1983) Cis-platinum ototoxicity: clinical experience and temporal bone histopathology. Laryngoscope 93:1554–1559.PubMedGoogle Scholar
  187. Swan SK (1997) Aminoglycoside nephrotoxicity. Semin Nephrol 17:27–33.PubMedGoogle Scholar
  188. Taguchi T, Nazneen A, Abid MR, Razzaque MS (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107–121.PubMedGoogle Scholar
  189. Talley RW, O’Bryan RM, Gutterman JU, Brownlee RW, McCredie KB (1973) Phase I clinical trial of platinum diamminedichloro-cis (NSC-119875). Cancer Chemother Rep 57:465–471.PubMedGoogle Scholar
  190. Tan CT, Hsu CJ, Lee SY, Liu SH, Lin-Shiau SY (2001) Potentiation of noise-induced hearing loss by amikacin in guinea pigs. Hear Res 161:72–80.PubMedGoogle Scholar
  191. Tanswell AK, Freeman BA (1995) Antioxidant therapy in critical care medicine. New Horizons 3:330–341.PubMedGoogle Scholar
  192. Tono T, Kiyomizu K, Matsuda K, Komune S, Usami S, Abe S, Shinkawa H. (2001) Different clinical characteristics of aminoglycoside-induced profound deafness with and without the 1555 A–>G mitochondrial mutation. ORL 63:25–30.PubMedGoogle Scholar
  193. Tran Ba Huy P, Bernard P, Schacht J (1986) Kinetics of gentamicin uptake and release in the rat: comparison of inner ear tissues and fluids with other organs. J Clin Invest 77:1492–1500.PubMedGoogle Scholar
  194. Tsukasaki N, Whitworth CA, Rybak LP (2000) Acute changes in cochlear potentials due to cisplatin. Hear Res 149:189–198.PubMedGoogle Scholar
  195. Umapathi T, Chaudhry V (2005) Toxic neuropathy. Curr Opin Neurol 18:574–580.PubMedGoogle Scholar
  196. Vakulenko SB, Mobashery S (2003) Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 16:430–450.PubMedGoogle Scholar
  197. van Ruijven MWM (2004) The cochlear targets of cisplatin. Thesis, University of Utrecht.Google Scholar
  198. van Ruijven MWM, De Groot JCMJ, Klis SFL, Smoorenburg G (2005a) Cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res 205: 241–248.Google Scholar
  199. van Ruijven MWM, De Groot JCMJ, Smoorenburg GF (2005b) Time sequence of degeneration pattern in the guinea pig cochlea during cisplatin administration. A quantitative histological study. Hear Res 197:44–54.Google Scholar
  200. Vermorken JB, Kapteijn TS, Hart AA, Pinedo HM (1983) Ototoxicity of cis-diammine- dichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol 19:53–58.PubMedGoogle Scholar
  201. Vermorken JB, van der Vijgh WJ, Klein I, Hart AA, Gall HE, Pinedo HM (1984) Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Can Treat Rep 68:505–513.Google Scholar
  202. Vital-Brazil O and Corrado AP (1957) The curariform action of streptomycin. J Pharm Exp Ther 120:452–459.Google Scholar
  203. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307–320.PubMedGoogle Scholar
  204. Wang J, Lloyd Faulconbridge RV, Fetoni A, Guitton MJ, Pujol R, Puel JL (2003) Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacol 45:380–393.Google Scholar
  205. Wang J, Ladrech S, Pujol R, Brabet P, Van De Water TR, Puel JL (2004) Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment prevents cisplatin-induced hearing loss. Cancer Res 64: 9217–9224.PubMedGoogle Scholar
  206. Ward DT, Maldonado-Perez D, Hollins L, Riccardi D (2005) Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor. J Am Soc Nephrol 16:1236–1244.PubMedGoogle Scholar
  207. Watanabe K, Inai S, Jinnouchi K, Baba S, Yagi T (2003) Expression of caspase-activated deoxyribonuclease (CAD) and caspase-3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs. Auris Nasis Larynx 30: 219–225.Google Scholar
  208. Webster M, Webster DB (1981) Spiral ganglion neuron loss following organ of Corti loss: A quantitative study. Brain Res 212:17–30.PubMedGoogle Scholar
  209. Wei X, Zhao L, Liu J, Dodel RC, Farlow MR, Du Y (2005) Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Neuroscience 131:513–521.PubMedGoogle Scholar
  210. Wersöll J, Lundquist PG, Björkroth B (1969) Ototoxicity of gentamicin. J Infect Dis 119:410–416.Google Scholar
  211. Wersöll J, Björkroth B, Flock A, Lundquist PG (1973) Experiments on ototoxic effects of antibiotics. Adv Oto-Rhino-Laryng 20:14–41.Google Scholar
  212. Williams SE, Smith DE, Schacht J (1987) Characteristics of gentamicin uptake in the isolated crista ampullaris of the inner ear of the guinea pig. Biochem Pharmacol 36:89–95.PubMedGoogle Scholar
  213. World Health Organization (2005) WHO Report 2005. global Tuberculosis Control: surveillance, planning, financing. Geneva: World Health Organization.Google Scholar
  214. Wright CG, Schaefer SD (1982) Inner ear histopathology in patients treated with cis-platinum. Laryngoscope 92:1408–1413.PubMedGoogle Scholar
  215. Wrzesniok D, Buszman E, Karna E, Palka J (2005) Melanin potentiates kanamycin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Pharmazie 60:439–443.PubMedGoogle Scholar
  216. Wu WJ, Sha SH, McLaren JD, Kawamoto K, Raphael Y, Schacht J (2001) Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear Res 158:165–178.PubMedGoogle Scholar
  217. Ylikoski, J, Pirvola, U, Suoqiang, Z, Eriksson, U, Solin, M-L, Miettinen, A, (1997) Aminoglycoside ototoxicity: high affinity receptors are expressed in secretory epithelia. Aud Neurosci 3:415–424.Google Scholar
  218. Ylikoski J, Xing-Qun L, Virkkala J, Pirvola U (2002) Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hear Res 163:71–61.PubMedGoogle Scholar
  219. Zappia JJ, Altschuler RA (1989) Evaluation of the effect of ototopical neomycin on spiral ganglion cell density in the guinea pig. Hear Res 40:29–38.PubMedGoogle Scholar
  220. Zhang M, Liu W, Ding D, Salvi R (2003) Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis. Neuroscience 120:191–205.PubMedGoogle Scholar
  221. Zhang S, Zhao C, Yu L (1997) [Analysis of sensorineural hearing loss in 77 children]. Lin Chuang Erh Pi Yen Hou Ko Tsa Chih Journal of Clinical Otorhinolaryngology 11:252–254.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Leonard P. Rybak
  • Andra E. Talaska
  • Jochen Schacht

There are no affiliations available

Personalised recommendations